The COVID-19 Research Database was used to assess the risk of COVID-19 infection in nearly 40,000 patients with atopic dermatitis. The incident rate ratio of COVID-19 diagnosis was recorded as was important information regarding dupilumab and its relationship to COVID-19 infection risk.
Atopic Dermatitis and COVID-19 Infection Risk
